Thomas E. Witzig

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.7K citations · Full text

Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

Robert A. Kyle, Morie A. Gertz, Thomas E. Witzig et al. · Mayo Clinic Proceedings · 2003 · 2.4K citations

Hematological Malignancy, Medicine, Hematology +5

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

Thomas E. Witzig, Leo I. Gordon, Fernando Cabanillas et al. · Journal of Clinical Oncology · 2002 · 1.2K citations

Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle et al. · Journal of Clinical Oncology · 2004 · 952 citations · Full text

POEMS syndrome: definitions and long-term outcome

Angela Dispenzieri, Robert A. Kyle, Martha Q. Lacy et al. · Blood · 2003 · 801 citations · Full text